ENTITY

Gain Therapeutics (GANX US)

Health CareUnited States
Gain Therapeutics, Inc. aspires to redefine drug discovery with its proprietary target identification platform. By identifying and optimizing allosteric binding sites that have never before been targeted, Gain is unlocking new treatment options for difficult-to-treat disorders characterized by protein misfolding.
more
Company Event11 Aug 2026 04:00 • Upcoming
Add To Calendar
Company Event12 May 2026 04:00 • Upcoming
Add To Calendar
Company Event05 May 2026 19:00 • Upcoming
Add To Calendar
Company Event28 Apr 2026 20:00 • Upcoming
Add To Calendar
Company Event28 Apr 2026 20:00 • Upcoming
Add To Calendar
x